Condition
Breast Cancer - Infiltrating Ductal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Breast Cancer - Infiltrating Ductal Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Argentina (1), Saudi Arabia (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Breast Cancer - Infiltrating Ductal Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Magtrace bracketing to guide lumpectomy and sentinel node biopsy | — | Madinah | Recruiting | Sep 28, 2026 |
| Combining hormone therapy with chemotherapy and HER2-targeted treatment before surgery for HER2+ breast cancer | Phase 2 | Gresham, Oregon and 3 other locations | Recruiting | Apr 2, 2026 |
| Oncoliq blood test for early detection of breast cancer | — | Buenos Aires, Buenos Aires | Recruiting | Jan 12, 2026 |
| SIRA-1000 radiofrequency ablation of lumpectomy margins | — | Galveston, Texas | Recruiting | Oct 3, 2025 |
All recruiting trials (4)
-
Magtrace bracketing to guide lumpectomy and sentinel node biopsy
This study tests whether Magtrace bracketing can help accurately locate the tumor and sentinel lymph node during breast-conserving surgery.
-
Combining hormone therapy with chemotherapy and HER2-targeted treatment before surgery for HER2+ breast cancer
This trial will try giving hormone (endocrine) therapy at the same time as chemotherapy and HER2-targeted drugs for adults with HR+, HER2+ breast cancer to see if tumors respond better before surgery.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
SIRA-1000 radiofrequency ablation of lumpectomy margins
This study tests whether using the SIRA-1000 radiofrequency device at the edge of the lumpectomy cavity during breast-conserving surgery can destroy remaining cancer cells in women 50 and older with ER/PR+ invasive ductal breast cancer.
Related topics
Quick answers
How many Breast Cancer - Infiltrating Ductal Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Argentina (1 trial), Saudi Arabia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.